Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells
about
Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunDMechanisms of bone anabolism regulated by statinsParathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathwayParathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsAdiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cellsPAPSS2 promotes alkaline phosphates activity and mineralization of osteoblastic MC3T3-E1 cells by crosstalk and Smads signal pathways.Role of osteoglycin in the linkage between muscle and bone.The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.Nectandrin A Enhances the BMP-Induced Osteoblastic Differentiation and Mineralization by Activation of p38 MAPK-Smad Signaling Pathway.SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.Regulation of bone and cartilage development by network between BMP signalling and transcription factors.Menin and bone metabolism.Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.Bioactive surface modification of hydroxyapatite.In vitro evaluation of osteoblast responses to carbon nanotube-coated titanium surfaces.Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts.The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth.Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases.Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression.Osteocompatibility of biofilm inhibitors.Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiationInduction of primitive streak and mesendoderm formation in monolayer hESC culture by activation of TGF-β signaling pathway by Activin B.Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells.Percutaneous gene therapy heals cranial defects.A mineralization-associated membrane protein plays a role in the biological functions of the peptide-coated bovine hydroxyapatite.Comparison Study of Bone Defect Healing Effect of Raw and Processed Pyritum in Rats.TGF-Beta Signaling in Bone with Chronic Kidney Disease
P2860
Q24293576-06B8D54B-39FA-4D7E-A255-0370B0F277B2Q24316533-FC1061E2-FE1F-4A84-A68B-4889DE870311Q26992028-AEE52FC5-9C34-4322-A1EA-5282BC4A8BF3Q28507612-6C6EBE67-229D-4C67-85B6-FF840138B071Q28573174-8FEAC80F-4E27-46E7-9DD3-0648707D9DDDQ33307781-38BC3C6E-0E1C-425C-A850-4234542D1E68Q34391648-60E34686-C168-469F-9514-AA5F09792710Q35874317-03592C23-1599-46B9-8812-1BA1B7391289Q35976816-7B2DE33E-60C4-4655-877E-396342FA67EFQ36724904-E1ACC7C0-DBE6-417F-AA6E-A69E2805DF1CQ37297703-795FAD4A-219B-4B14-9175-000FEAADD5B8Q37667917-9FC6054E-333E-4B76-8A40-7C36DE062536Q37976669-ABC55AA6-C12A-43C8-8F46-C3C1AB2DCF90Q38006379-1FA0B551-6CF3-4BFB-8269-AF96C690385EQ38356545-2DE3FAD7-7FF9-42B1-843C-611D332D36DCQ39124654-8AE0FF78-2316-4DAF-BFAD-12F0861651E9Q39558522-4BF5F906-A6CC-4B93-B8D0-BD8E28E90D83Q39708889-34966AD8-86FF-4FFD-8335-67D16C2F81DAQ39825827-1FFBB185-3AA3-463F-A23F-C842DCF8E0F6Q39884416-85D8E537-D3AA-472E-91D2-1D5AEFFEADF9Q39918764-5E185AE7-3160-4213-BF73-25AD9202A8ABQ41599948-D952951F-A0A9-4C27-A705-38A31E489FA0Q42036660-8DC08212-0881-474D-BBFA-41D55117E002Q42039345-D3555ACB-4694-4D88-B907-40815CE11DE7Q42823467-64F3E133-AE92-4E28-A258-E3EB5C443705Q44072112-221B589B-8A92-4522-B12D-A2C0DBD31D17Q45886841-BD895081-9B06-460B-9DF9-D8CD61F99B2DQ46279287-5CF34061-A39D-441A-AA77-964451ECC78FQ47599966-C83A0530-CF77-4699-BD36-60C8F3113A2DQ58789309-F81CB45E-AF31-482F-874D-D0F9E59829D9
P2860
Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells
description
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Juli 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/07/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/07/01)
@nl
наукова стаття, опублікована в липні 2002
@uk
مقالة علمية (نشرت في يوليو 2002)
@ar
name
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@ast
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@en
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@nl
type
label
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@ast
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@en
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@nl
prefLabel
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@ast
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@en
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@nl
P2093
P3181
P1476
Smad3 promotes alkaline phosph ...... of osteoblastic MC3T3-E1 cells
@en
P2093
Hideaki Sowa
Hiroshi Kaji
Kazuo Chihara
Toru Yamaguchi
Toshitsugu Sugimoto
P304
P3181
P356
10.1359/JBMR.2002.17.7.1190
P577
2002-07-01T00:00:00Z